[Pressure-pulsed cortisone therapy in smelling disorders].
There is lack of a clear strategy in the treatment of smelling disorders with corticoids. We investigated the olfactory function via the validated Threshold-Discrimination-Identification Score (TDI) in patients with sinonasal, post-URTI or idiopathic disorders before and after topic corticoid pressure-pulsed inhalation therapy (compared to systemic corticoid administration). With both forms of therapy 20% of patients showed a clinically relevant increase of their TDI score of 6 points regardless of sex, age or duration of disease. The pressure pulsed inhalation therapy is an efficient, accepted therapeutic option with less side effects.